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Abstract:
Leptomeningitis is a rare central nervous system manifestation of rheumatoid arthritis (RA), generally in patients with established chronic rheumatoid disease. We report a 41-year-old man without previous RA or psychiatric disorder presenting with an acute neuropsychiatric disturbance and polyarthralgia. MRI brain showed asymmetric bi-frontal leptomeningitis, confirmed on ( 18 F)-fluoro-D-glucose-positron emission tomography. Other investigations revealed highly positive serum and CSF anti-cyclic citrullinated peptide. A leptomeningeal biopsy showed necrotising leptomeningeal inflammation with ill-defined granulomas and lymphoplasmacytic infiltrate without organisms. Prolonged high-dose corticosteroids and then rituximab resulted in recovery.
Chronic leptomeningitis can present with an acute neuropsychiatric disorder. We highlight that early rheumatoid disease can, rarely, cause a chronic leptomeningitis, reversible with immunotherapy.
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Introduction:
Leptomeningitis is a rare manifestation of central nervous system involvement in rheumatoid arthritis (RA), usually presenting with focal neurological signs in patients with established disease. We report a patient with only a short history of polyarthralgia, who presented with an acute neuropsychiatric disturbance, and a chronic fronto-temporal leptomeningitis, which turned out on serology and biopsy to reflect rheumatoid disease. He was successfully treated with corticosteroids and rituximab. Four months later, he began a graded return to work.
Clinical Summary:
A previously well 41-year-old man of Nicaraguan origin was brought to the Emergency Department by co-workers, concerned about a four-day deterioration in mental state. His psychiatric symptoms included elevated and irritable mood; increased energy and reduced sleep; out of character risk-taking; grandiose and persecutory delusions; and plans to spend large sums of money on a sports car and property development. This was preceded by several months of reduced frustration tolerance, as reported by his wife. He complained only of chronic headache and migratory palindromic, large and small joint polyarthritis for 18-months, self-treated with indomethacin for a few weeks due to suspected gout. He was a non-smoker with a social alcohol consumption and denied recreational drug use. Much later it emerged that three-months before this he had seen a private neurologist about transient sensory symptoms and leg weakness. MRI brain showed early leptomeningeal changes, however he did not reveal this to his family and failed to attend his scheduled followup consultations, in hindsight likely due to early executive dysfunction.
On examination he was afebrile, without focal neurological signs, normal fundi and a supple neck. He was agitated, disinhibited and irritable, with pressured speech, mild thought disorder, persecutory and grandiose delusions. He could not recall recent events and was disorientated in time. His right elbow was swollen and painful. There were no nodules, rashes, nail changes or lymphadenopathy. All tests for drug-induced, infective or toxic/metabolic causes were negative ( Supplementary Table 1 ). Brain Rheumatoid meningitis more often involves the pachymeninges rather than the leptomeninges and appears granulomatous, occasionally with rheumatoid nodules and features of vasculitis. A confident diagnosis can only be made from tissue biopsy (2) .
There is inflammation with fibrinoid necrosis surrounded by lymphocytes and epithelioid histiocytes, with variable plasma cell infiltrate (1). Recent reviews of 29
(1) and 48 (2) rheumatoid meningitis patients suggest focal neurological changes, hemiparesis or hemi-sensory changes mimicking stroke or focal epilepsy are the usual presenting features (3), with about 2/3 of cases demonstrating asymmetric meningeal involvement on MRI (1). Most rheumatoid meningitis patients were known to have RA long before they developed leptomeningitis; ten reports suggest a neuropsychiatric disturbance, coinciding with seizures, myoclonus or hemiparesis (2) .
Only six reports document neurological manifestations without prior RA, with joint symptoms occurring with or soon after the onset of rheumatoid meningitis (2, (4) (5) (6) .
Consensus about the treatment of rheumatoid meningitis is lacking. Corticosteroids and other disease-modifying immunosuppressive agents have been reported, including methotrexate, cyclophosphamide (2, 7), as well as tumour necrosis factor-alpha antagonists (8) . This is the third reported case of rheumatoid meningitis successfully treated with rituximab (8, 9) . The treatment was complicated by evidence of previous TB exposure. However, lack of systemic involvement, normal CSF parameters and strongly positive serum and CSF anti-CCP favoured rheumatoid meningitis over TB meningitis. We found no previous reports of rheumatoid meningitis presenting as an isolated acute neuropsychiatric disturbance, responsive to immunotherapy.
This case illustrates that rheumatoid disease needs to be considered in patients presenting with leptomeningitis, even in those without established RA. Clinical evaluation of joint symptoms and signs, anti-CCP (as well as rheumatoid factor) and then meningeal biopsy will confirm the diagnosis. The clinical features of this case crossed numerous disciplines, highlighting the importance of cooperation and collaboration between specialties.
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Highlights:
 Rheumatoid disease is a rare cause of leptomeningitis and can occur before a diagnosis of rheumatoid arthritis is made. 
